Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
FAK inhibitor.
α1A-adrenergic antagonist.
ALK inhibitor.
Antifungal agent with neuroprotective activity....
NSAID; PG synthetase inhibitor.
TLR4 inhibitor.
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
Curcumin derivative.
Peptide, involved in neutrophil activation; FPR...
Enalapril metabolite; ACE inhibitor.
Peptide, derivative of AT II, involved in vasoc...
PLK1 inhibitor.
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
Triterpene sapogenin found in species of Panax;...
Pneumonia antigen
MAO-A inhibitor.
Pt-based DNA cross-linker.
Nitrofuran derivative.
JAK2 inhibitor.
Vitamin E component